ArticleArthritis & rheumatology (Hoboken, N.J.)2025

Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm Trial.

George E Georges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.